Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2016, Article ID 3861461, 8 pages
http://dx.doi.org/10.1155/2016/3861461
Research Article

Melatonin in Epilepsy: A New Mathematical Model of Diurnal Secretion

1Department of Paediatrics and Developmental Age Neurology, School of Medicine in Katowice, Medical University of Silesia, Ulica Medyków 16, 40-752 Katowice, Poland
2Department of Medical Physics, Maria Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Ulica Wybrzeże Armii Krajowej 15, 44-101 Gliwice, Poland
3Faculty of Automatic Control, Electronics and Computer Science Biomedical Engineering, Silesian University of Technology, Ulica Akademicka 2A, 44-100 Gliwice, Poland

Received 28 March 2016; Revised 5 June 2016; Accepted 13 June 2016

Academic Editor: Darío A. Castroviejo

Copyright © 2016 Justyna Paprocka et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Paprocka, “Melatonin in epilepsy,” Neurologia Dziecięca, vol. 24, pp. 37–40, 2003. View at Google Scholar
  2. J. Paprocka, R. Dec, E. Jamroz, and E. Marszał, “Melatonin and childhood refractory epilepsy—a pilot study,” Medical Science Monitor, vol. 16, no. 9, pp. CR389–CR396, 2010. View at Google Scholar · View at Scopus
  3. A. Brzezinski, “Melatonin in humans,” The New England Journal of Medicine, vol. 336, no. 3, pp. 186–195, 1997. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Praninskiene, I. Dumalakiene, R. Kemezys, M. Mauricas, and A. Jucaite, “Melatonin secretion in children with epilepsy,” Epilepsy and Behavior, vol. 25, no. 3, pp. 315–322, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. E. G. A. van Golde, T. Gutter, and A. W. de Weerd, “Sleep disturbances in people with epilepsy; prevalence, impact and treatment,” Sleep Medicine Reviews, vol. 15, no. 6, pp. 357–368, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Coppola, G. Iervolino, M. Mastrosimone, G. La Torre, F. Ruiu, and A. Pascotto, “Melatonin in wake-sleep disorders in children, adolescents and young adults with mental retardation with or without epilepsy: a double-blind, cross-over, placebo-controlled trial,” Brain and Development, vol. 26, no. 6, pp. 373–376, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Gupta, S. Aneja, and K. Kohli, “Add-on melatonin improves sleep behavior in children with epilepsy: randomized, double-blind, placebo-controlled trial,” Journal of Child Neurology, vol. 20, no. 2, pp. 112–115, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Hashimoto, K. Nakamura, S. Honma, and K. I. Honma, “Free-running of plasma melatonin rhythm prior to full manifestation of a non-24 hour sleep–wake syndrome,” Psychiatry and Clinical Neurosciences, vol. 52, no. 2, pp. 264–265, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Hashimoto, K. Nakamura, S. Honma, and K.-I. Honma, “Free-running circadian rhythm of melatonin in a sighted man despite a 24-hour sleep pattern: a non-24-hour circadian syndrome,” Psychiatry and Clinical Neurosciences, vol. 51, no. 3, pp. 109–114, 1997. View at Publisher · View at Google Scholar · View at Scopus
  10. B. Claustrat, J. Brun, and G. Chazot, “The basic physiology and pathophysiology of melatonin,” Sleep Medicine Reviews, vol. 9, no. 1, pp. 11–24, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. D. R. Wagner, “Disorders of the circadian sleep-wake cycle,” Neurologic Clinics, vol. 14, no. 3, pp. 651–670, 1996. View at Publisher · View at Google Scholar · View at Scopus
  12. D. R. Wagner, “Circadian rhythm sleep disorders,” Current Treatment Options in Neurology, vol. 1, no. 4, pp. 299–307, 1999. View at Publisher · View at Google Scholar
  13. F. Waldhauser, G. Weiszenbacher, E. Tatzer et al., “Alterations in nocturnal serum melatonin levels in humans with growth and aging,” Journal of Clinical Endocrinology and Metabolism, vol. 66, no. 3, pp. 648–652, 1988. View at Publisher · View at Google Scholar · View at Scopus
  14. E. B. Klerman, H. B. Gershengorn, J. F. Duffy, and R. E. Kronauer, “Comparisons of the variability of three markers of the human circadian pacemaker,” Journal of Biological Rhythms, vol. 17, no. 2, pp. 181–193, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Arendt, “Melatonin: characteristics, concerns, and prospects,” Journal of Biological Rhythms, vol. 20, no. 4, pp. 291–303, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. M. A. St Hilaire, C. Gronfier, J. M. Zeitzer, and E. B. Klerman, “A physiologically based mathematical model of melatonin including ocular light suppression and interactions with the circadian pacemaker,” Journal of Pineal Research, vol. 43, no. 3, pp. 294–304, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. P. C. Zee and M. V. Vitiello, “Circadian rhythm sleep disorder: irregular sleep wake rhythm,” Sleep Medicine Clinics, vol. 4, no. 2, pp. 213–218, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Phillips and R. E. Appleton, “Systematic review of melatonin treatment in children with neurodevelopmental disabilities and sleep impairment,” Developmental Medicine and Child Neurology, vol. 46, no. 11, pp. 771–775, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Lewy, J. Emens, A. Jackman, and K. Yuhas, “Circadian uses of melatonin in humans,” Chronobiology International, vol. 23, no. 1-2, pp. 403–412, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. R. L. Sack, D. Auckley, R. R. Auger et al., “Circadian rhythm sleep disorders: part II, advanced sleep phase disorder, delayed sleep phase disorder, free-running disorder, and irregular sleep–wake rhythm. An American Academy of Sleep Medicine Review,” Sleep, vol. 30, no. 11, pp. 1484–1501, 2007. View at Google Scholar · View at Scopus
  21. D. Martinez and M. D. C. S. Lenz, “Circadian rhythm sleep disorders,” Indian Journal of Medical Research, vol. 131, no. 2, pp. 141–149, 2010. View at Google Scholar · View at Scopus
  22. P. Monteleone, A. Tortorella, R. Bordello, M. Natale, P. Cassandro, and M. Maj, “Suppression of nocturnal plasma melatonin levels by evening administration of sodium valproate in healthy humans,” Biological Psychiatry, vol. 41, no. 3, pp. 336–341, 1997. View at Publisher · View at Google Scholar · View at Scopus
  23. M. M. S. Jan, “Melatonin for the treatment of handicapped children with severe sleep disorders,” Pediatric Neurology, vol. 23, no. 3, pp. 229–232, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. G. Pillar, E. Shahar, N. Peled, S. Ravid, P. Lavie, and A. Etzioni, “Melatonin improves sleep-wake patterns in psychomotor retarded children,” Pediatric Neurology, vol. 23, no. 3, pp. 225–228, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Okawa and M. Uchiyama, “Circadian rhythm sleep disorders: characteristics and entrainment pathology in delayed sleep phase and non-24 sleep-wake syndrome,” Sleep Medicine Reviews, vol. 11, no. 6, pp. 485–496, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. S. G. Sajith and D. Clarke, “Melatonin and sleep disorders associated with intellectual disability: a clinical review,” Journal of Intellectual Disability Research, vol. 51, no. 1, pp. 2–13, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. C. W. Bazil, D. Short, D. Crispin, and W. Zheng, “Patients with intractable epilepsy have low melatonin, which increases following seizures,” Neurology, vol. 55, no. 11, pp. 1746–1748, 2000. View at Publisher · View at Google Scholar · View at Scopus
  28. Ö. Yalýn, F. Arman, F. Erdogan, and M. Kula, “A comparison of the circadian rhythms and the levels of melatonin in patients with diurnal and nocturnal complex partial seizures,” Epilepsy and Behavior, vol. 8, no. 3, pp. 542–546, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Molina-Carballo, A. Muñóz-Hoyos, T. Rodríguez-Cabezas, and D. Acuña-Castroviejo, “Day-night variations in melatonin secretion by the pineal gland during febrile and epileptic convulsions in children,” Psychiatry Research, vol. 52, no. 3, pp. 273–283, 1994. View at Publisher · View at Google Scholar · View at Scopus
  30. M. K. Pavlova, S. A. Shea, F. A. J. L. Scheer, and E. B. Bromfield, “Is there a circadian variation of epileptiform abnormalities in idiopathic generalized epilepsy?” Epilepsy and Behavior, vol. 16, no. 3, pp. 461–467, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. C. W. Bazil, “Effects of antiepileptic drugs on sleep structure: are all drugs equal?” CNS Drugs, vol. 17, no. 10, pp. 719–728, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Djeridane and Y. Touitou, “Chronic diazepam administration differentially affects melatonin synthesis in rat Pineal and Harderian glands,” Psychopharmacology, vol. 154, no. 4, pp. 403–407, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. W. Braam, R. Didden, M. G. Smits, and L. M. G. Curfs, “Melatonin for chronic insomnia in Angelman syndrome: a randomized placebo-controlled trial,” Journal of Child Neurology, vol. 23, no. 6, pp. 649–654, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. O. Bruni, D. Alonso-Alconada, F. Besag et al., “Current role of melatonin in pediatric neurology: clinical recommendations,” European Journal of Paediatric Neurology, vol. 19, no. 2, pp. 122–133, 2015. View at Publisher · View at Google Scholar · View at Scopus